Search
Align Summit 2026: NeuroSkye Therapeutics is focused on getting medicines more efficiently across the blood-brain-barrier - both through its proprietary model and through a peptide based shuttle
Founder Fong Cho describes the unmet need, and the benefits of using the company's model and shuttle. She believes that NeuroSkye's peptide approach to its shuttle makes it an ideal platform to work together with a wide spectrum of therapeutic modalities. Coverage brought to you by
2 hours ago
.png){kind=logo}